View Cart (0 items)

Pharmaceutical

Philip Blake to head Bayer’s US operations

PITTSBURGH and WAYNE, N.J. — German-based Bayer AG announced Tuesday that Philip Blake has been named Senior Bayer Representative (SBR) USA. The appointment is effective July 1. Blake succeeds Greg
Read More

Pfizer to cut workforce in response to slowing demand for Lipitor

CORK, Ireland — Pfizer announced it is eliminating 177 jobs at its plants in Ireland in response to a fall in demand for anti-cholesterol drug Lipitor, The Irish Times
Read More

Study details foreign efforts to lure biopharmaceutical companies

Despite increasing budget pressures, countries around the world are making substantial investments in pro-innovation policies and programs to lure the biopharmaceutical research sector away from the U.S., finds a
Read More

US may speed approval of ''breakthrough'' drugs

WASHINGTON — Reuters reports, experimental drugs that show a big effect early in development for treating serious or life-threatening diseases would get a faster and cheaper path to U.S. approval,
Read More

Pharmaceutical industry leaders to examine global supply network challenges, solutions at ISPE Conference

TAMPA, Fla. — ISPE will host an in-depth two-day conference that will bring together top industry leaders and regulators to examine global supply network challenges and solutions. The event, “Designing,
Read More

Multi-tasking Titrator

JM Science’s Potentiometric Titrator (COM-1700) can run four titrations and stirrers that easily allow end user to do different types of titration including potentiometric, photometric, polarization, and conductometric titrations in
Read More

Pfizer, BYU settle Celebrex lawsuit for $450M

One month from trial date, Brigham Young University and Pfizer Inc. settled a lawsuit Tuesday for $450 million over whether the Utah school had been cheated out of billions of
Read More

Novartis to Buy Fougera Pharmaceuticals for $1.5 Billion

Novartis International has agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, for $1.525 billion in cash, reported by The New York Times. Under the terms of
Read More

Pfizer Q1 profit falls 19 percent

The Associated Press reports, Pfizer Inc. said Tuesday that its first-quarter profit fell 19 percent, mainly because new generic competition to its blockbuster cholesterol pill Lipitor cut U.S. sales by
Read More

Warner Chilcott to explore sale of company

Specialty pharmaceutical company Warner Chilcott Plc said it would explore strategic options, including preliminary talks with potential buyers, Reuters reports. The company said it hired Goldman Sachs as its financial
Read More